Pular para o conteúdo principal
  • Parceiros aprovados
  • Sobre a ELGA
    • Sobre a ELGA
    • Carreiras
    • Eventos
  • Apoio
    • Planeamento laboratorial
    • Registar um produto
    • Register Your Product (USA & Canada Only)
  • Contacto
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • 日本
  • 中国
Início ELGA LabWater
  • Produtos
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • Gama completa dos produtos ELGA
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Knowledge
    • Blogue
    • Estudos de caso
    • Água ultrapura
    • Guias e Livros brancos
  • Produtos
    • PURELAB
    • CENTRA
    • MEDICA
      • Hubgrade
      • MEDICA BIOX
    • BIOPURE
    • Gama completa dos produtos ELGA
      • PURELAB® Classic
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
      • Hochleistungsflüssigkeitschromatographie (HPLC)
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Knowledge
    • Blogue
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • Estudos de caso
      • A Abbott Diagnostics escolhe os sistemas ELGA MEDICA no Sul da Ásia
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Argenta chooses DKSH New Zealand to deliver Ultrapure water in Animal Pharma
      • Clean Water for a Clean Future
      • LS Scientific & ELGA deliver UltraPure water to the NAFDAC Laboratory
      • Lifebrain Group chooses ELGA as water partner for new modern 24/7 PCR-COVID-19 laboratory in Vienna, Austria.
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA: a maior empresa de diagnósticos médicos do Brasil
      • A ELGA ajuda os laboratórios de imunosserologia a maximizar o tempo de atividade
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • Importância da água ultrapura Tipo 1+ para o desenvolvimento de medicamentos genéricos
      • MEDICA® Pro selecionado para analisadores Siemens ADVIA® no City General Hospital
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex: um sistema de formação ideal para o método de investigação atual
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • Desvendar os segredos da Antártida com a ajuda de água ultrapura
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • Água ultrapura
    • Guias e Livros brancos
      • Pureza da água de HPLC
      • HPLC no setor farmacêutico
      • Redução de riscos clínicos
      • Sustentabilidade
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • 日本
  • 中国
  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Impressum
  • Início
  • Improving the Routine Analysis of Antipsychotic Drugs
Clinical & Pharma
Analytical Chemistry

Improving the Routine Analysis of Antipsychotic Drugs

20 set 2021
- by Dr Alison Halliday

Mind drugs

Researchers validate a new LC-MS/MS method for quantifying 38 antipsychotics and metabolites in plasma for therapeutic drug monitoring and forensic applications.

Antipsychotic medications have revolutionised the treatment of psychiatric disorders. These substances fall into two main classes – first-generation antipsychotics (FGAs), which were developed in the late 1950s for the treatment of psychosis symptoms. In recent decades, these have largely been replaced by second-generation antipsychotics (SGAs) – or ‘atypicals’.

The shift towards SGAs has partly been driven by the lower risk of developing severe movement problems than FGAs. However, atypicals may be more likely to cause other potentially serious side effects, including weight gain, heart problems and diabetes.

The number of patients being prescribed antipsychotics is growing worldwide, despite these safety concerns. The increasing off–label use of SGAs mainly consists of the treatment of anxiety and insomnia disorders in adults and ADHD in children.

Clinical and Forensic Analysis

The risk of undesired side effects from antipsychotics, combined with the increased use in children, drives a need for strict therapeutic drug monitoring. From a forensics perspective, more daytime traffic accidents are caused by psychotropic medication (combined with alcohol) than illicit drugs.

But many of the current methods used for clinical and forensic purposes are limited – such as analysing only a small number of antipsychotics or involving long, complex protocols.

In a new study, published in the Journal of Chromatography B, researchers develop a multi-analyte liquid chromatography triple quadrupole mass spectrometry method for the quantification of 38 antipsychotic drugs in plasma.1

A Fully Validated Method

The researchers extracted samples by a straightforward liquid-liquid extraction with methyl–tertiary–butyl–ether and the compounds of interest were chromatographically separated within six minutes. They showed that the calibration curves covered the recommended therapeutic range for all compounds, in addition to levels above and below for most substances.

After successfully validating the method according to relevant European Medicines Agency (EMA) guidelines, the team applied their new method to the analysis of samples from 137 medico-legal cases. They found 46 samples that were positive for one or more antipsychotic drugs, with their results confirming the relatively common use of the SGAs quetiapine and olanzapine, as well as the continued presence of the FGA haloperidol in Europe.

The researchers used ultrapure water produced in–house from an ELGA PURELAB® laboratory water purification system, minimising the risk of adding trace contaminants that may affect their results.

Application to Routine Analysis

In this study, researchers create a new fully validated, time-efficient quantitative multi-analyte method for therapeutic drug monitoring and forensic analysis of a wide range of antipsychotic medications in plasma.

The sample preparation and chromatographic settings were previously successfully applied in the quantification of other psychoactive drug classes (antidepressants and benzodiazepines), allowing for easy transitioning or merging of methods.

The method was further applied to more than 100 medico-legal cases and its performance was thoroughly evaluated through proficiency testing schemes.

Why Choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. Our dedication to ultrapure and pure water is a guarantee that we will continue to provide the best solutions with the best service.

Reference:

  1. Degreef, M. et al. Multi–analyte LC-MS/MS quantification of 38 antipsychotics and metabolites in plasma: Method validation & application to routine analyses. J Chromatog B 2021;1179:122867 doi: https://doi.org/10.1016/j.jchromb.2021.122867

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

HPLC Pharma

Optimise your HPLC to avoid water contamination
when manufacturing life-saving drugs.

Understand the role of HPLC and different levels of water purity in drug manufacture, analysis and pharmaceutical quality assurance

              Click Here 

 

  • Enquiry
  • Obter uma cotação
  • Agende uma demonstração
  • Encontre um parceiro aprovado

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Obter uma cotação

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Agende uma demonstração

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Headquarters

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Sede da ELGA LabWater

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Estudos de caso

  • Abbott Diagnostics
  • DASA Medical Diagnostics
  • NeoDIN Medical Institute
  • North Staffordshire NHS Trust
  • Olsberg Vocational College

Recursos

  • Saber mais sobre água ultrapura
  • Guias e Livros Brancos
  • Tecnologias de purificação
  • Aplicações
  • Impurezas na água

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • Idioma
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Outros sítios Web da Veolia
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies

© VWS (UK) Ltd. negociando como ELGA LabWater.2022-Todos os direitos reservados.
ELGA é a marca global de água para laboratórios da Veolia.

  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Impressum
Elga Veolia
TOP

© 2017 ELGA Veolia